3D Systems Yönetim

Yönetim kriter kontrolleri 1/4

3D Systems CEO'su Jeff Graves, May2020 tarihinde atandı, in görev süresi 4.5 yıldır. in toplam yıllık tazminatı $ 6.54M olup, şirket hissesi ve opsiyonları dahil olmak üzere 13% maaş ve 87% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.77% ine doğrudan sahiptir ve bu hisseler $ 3.30M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 1.9 yıl ve 7.4 yıldır.

Anahtar bilgiler

Jeff Graves

İcra Kurulu Başkanı

US$6.5m

Toplam tazminat

CEO maaş yüzdesi	13.0%
CEO görev süresi	4.5yrs
CEO sahipliği	0.8%
Yönetim ortalama görev süresi	1.9yrs
Yönetim Kurulu ortalama görev süresi	7.4yrs

Son yönetim güncellemeleri

Recent updates

Analyst Estimates: Here's What Brokers Think Of 3D Systems Corporation (NYSE:DDD) After Its Yearly Report

Mar 01

3D Systems: Another Difficult Year Ahead

Feb 29

3D Systems: Strategic Missteps Uncovered

Feb 15

3D Systems (NYSE:DDD) Is Carrying A Fair Bit Of Debt

Feb 15

3D Systems Needs To Do Better

Nov 30

At US$4.68, Is It Time To Put 3D Systems Corporation (NYSE:DDD) On Your Watch List?

Nov 15

3D Systems: No Relief In Sight

Oct 19

3D Systems Corporation (NYSE:DDD) Shares Could Be 35% Below Their Intrinsic Value Estimate

Oct 05

3D Systems And The Merger Drama

Sep 27

3D Systems: The Future Of 3D Printing And Regenerative Healthcare?

Sep 20

3D Systems: In Search Of Scale

Jul 08

Is 3D Systems (NYSE:DDD) Weighed On By Its Debt Load?

Jun 26

Does 3D Systems (NYSE:DDD) Have A Healthy Balance Sheet?

Feb 22

3D Systems inks 3-year technical partnership with Stewart-Haas Racing

Jan 25

3D Systems: No Hurry - Still Not There Yet

Dec 26

3D Systems stock gains on promising long-term view after mixed Q3 results

Nov 09

3D Systems (NYSE:DDD) Has Debt But No Earnings; Should You Worry?

Nov 06

CEO Tazminat Analizi

Jeff Graves'un ücretlendirmesi 3D Systems'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jun 30 2024	n/a	n/a	-US$348m
Mar 31 2024	n/a	n/a	-US$350m
Dec 31 2023	US$7m	US$850k	-US$363m
Sep 30 2023	n/a	n/a	-US$96m
Jun 30 2023	n/a	n/a	-US$122m
Mar 31 2023	n/a	n/a	-US$126m
Dec 31 2022	US$6m	US$850k	-US$123m
Sep 30 2022	n/a	n/a	-US$104m
Jun 30 2022	n/a	n/a	US$227m
Mar 31 2022	n/a	n/a	US$250m
Dec 31 2021	US$9m	US$837k	US$322m
Sep 30 2021	n/a	n/a	US$308m
Jun 30 2021	n/a	n/a	-US$57m
Mar 31 2021	n/a	n/a	-US$85m
Dec 31 2020	US$6m	US$489k	-US$150m

Tazminat ve Piyasa: Jeff 'nin toplam tazminatı ($USD 6.54M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 2.14M ).

Tazminat ve Kazançlar: Jeff şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

Jeff Graves (63 yo)

4.5yrs

Görev süresi

US$6,535,630

Tazminat

Dr. Jeffrey Alan Graves, also known as Jeff, is Director of Integra LifeSciences Corporation. He is Independent Director of Integra LifeSciences Holdings Corporation from December 12, 2023. Dr. Graves is P...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Jeffrey Graves	President	4.5yrs	US$6.54m	0.77% $ 3.3m
Reji Puthenveetil	Executive Vice President of Industrial Solutions	4.3yrs	US$2.31m	0.27% $ 1.2m
Jeffrey Creech	Executive VP	less than a year	US$845.99k	0.13% $ 567.5k
Phyllis Nordstrom	Executive VP	3.3yrs	US$2.10m	0.12% $ 527.3k
Charles Hull	Co-Founder	no data	Veri yok	0.43% $ 1.8m
Joseph Zuiker	Executive Vice President of Engineering & Operations	1.9yrs	Veri yok	0.11% $ 485.6k
Michael McCloskey	Treasurer & VP of Investor Relations	no data	Veri yok	Veri yok
Andrew Wright	Senior VP of General Counsel & Corporate Secretary	less than a year	Veri yok	Veri yok
Harriss Currie	President - Regenerative Medicine	less than a year	Veri yok	0.096% $ 410.3k

1.9yrs

Ortalama Görev Süresi

60.5yo

Ortalama Yaş

Deneyimli Yönetim: DDD 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 1.9 yıl), bu da yeni bir ekibin varlığını gösteriyor.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Jeffrey Graves	President	4.8yrs	US$6.54m	0.77% $ 3.3m
Charles Hull	Co-Founder	no data	Veri yok	0.43% $ 1.8m
Jim Kever	Independent Director	28.8yrs	US$220.00k	0.36% $ 1.6m
Thomas Erickson	Independent Director	9yrs	US$228.76k	0.24% $ 1.0m
Kevin Moore	Independent Director	25.1yrs	US$245.00k	0.18% $ 776.4k
Charles McClure	Independent Chairman of the Board	7.7yrs	US$400.00k	0.11% $ 489.8k
William Curran	Independent Director	16.8yrs	US$255.00k	0.11% $ 456.0k
John Tracy	Independent Director	7.4yrs	US$240.00k	0.11% $ 485.3k
Stephen Klasko	Chair of Medical Advisory Board	2.5yrs	Veri yok	Veri yok
Malissia Clinton	Independent Director	5.7yrs	US$240.00k	0.094% $ 402.8k
Vasant Padmanabhan	Independent Director	3.9yrs	US$216.24k	0.088% $ 378.0k
Claudia Drayton	Independent Director	2.9yrs	US$218.11k	0.075% $ 318.6k

7.4yrs

Ortalama Görev Süresi

70yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: DDD 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 7.4 yıldır).

3D Systems Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

3D Systems Corporation Announces Executive Changes

3D Systems Corporation Appoints Andrew Johnson as Interim Chief Financial Officer

3D Systems Appoints Jeffrey Creech as Chief Financial Officer

Independent Director recently bought US$228k worth of stock

Systems Corporation Appoints Margaret E. Wicklund as Senior Vice President and Chief Accounting Officer

3D Systems Corporation Announces CFO Changes

Recent updates

3D Systems: Waiting For More Clarity On The Profitability Path

3D Systems Corporation to Report Q3, 2024 Results on Nov 25, 2024

Price target decreased by 39% to US$3.06

3D Systems Empowers Innovation, Transforms Industries with New Products At Formnext 2024

3D Systems Corporation(NYSE:DDD) dropped from S&P 600 Industrials (Sector)

3D Systems Expands High Precision Investment Casting Portfolio with QuickCast Air

3D Systems: Green Shoots Amidst Ongoing Macro Challenges

3D Systems Corporation Updates Earnings Guidance for the Full-Year 2024

3D Systems Corporation to Report Q1, 2024 Results on Aug 19, 2024

3D Systems Corporation to Report First Half, 2024 Results on Aug 26, 2024

3D Systems Corporation announced delayed 10-Q filing

3D Systems Introduces Ext 800 Titan Pellet - Expanding Accessibility of Industrial Extrusion Platform

3D Systems: Don't Print Your Hopes Up At The 52-Week Low

3D Systems Corporation announced delayed 10-Q filing

3D Systems Announces FDA Clearance for 3D-Printed Pek Cranial Implants

3D Systems Receives NYSE Notice Regarding Late Form 10-K Filing

Analyst Estimates: Here's What Brokers Think Of 3D Systems Corporation (NYSE:DDD) After Its Yearly Report

3D Systems Corporation announced delayed annual 10-K filing

Full year 2023 earnings: EPS and revenues miss analyst expectations

3D Systems Corporation Reports Unaudited Consolidated Impairment Charges Results for the Fourth Quarter Ended December 31, 2023

3D Systems: Another Difficult Year Ahead

3D Systems Introduces First Multi-Material, One-Piece Jetted Denture Solution

3D Systems: Strategic Missteps Uncovered

3D Systems Corporation to Report Q4, 2023 Results on Feb 27, 2024

3D Systems (NYSE:DDD) Is Carrying A Fair Bit Of Debt

3D Systems Corporation Announces Executive Changes

3D Systems Corporation Appoints Andrew Johnson as Interim Chief Financial Officer

3D Systems Appoints Jeffrey Creech as Chief Financial Officer

3D Systems Needs To Do Better

Independent Director recently bought US$228k worth of stock

At US$4.68, Is It Time To Put 3D Systems Corporation (NYSE:DDD) On Your Watch List?

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

New minor risk - Share price stability

Price target decreased by 12% to US$7.63

3D Systems Corporation to Report Q3, 2023 Results on Nov 08, 2023

3D Systems: No Relief In Sight

Systems Corporation Appoints Margaret E. Wicklund as Senior Vice President and Chief Accounting Officer

3D Systems Corporation (NYSE:DDD) Shares Could Be 35% Below Their Intrinsic Value Estimate

3D Systems And The Merger Drama

3D Systems Corporation Announces CFO Changes

3D Systems: The Future Of 3D Printing And Regenerative Healthcare?

the Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of 3D Systems Corporation Publicly-Traded Common Stock

Price target decreased by 11% to US$8.20

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

3D Systems Corporation Revises Earnings Guidance for the Full Year 2023

3D Systems Corporation to Report Q2, 2023 Results on Aug 09, 2023

3D Systems Introduces New Materials Engineered to Expand Capabilities of SLA and Figure 4 Platforms

Consensus EPS estimates upgraded to US$0.64 loss

New minor risk - Shareholder dilution

3D Systems: In Search Of Scale

Is 3D Systems (NYSE:DDD) Weighed On By Its Debt Load?

3D Systems Corporation (NYSE:DDD) submitted a non-binding proposal to acquire Stratasys Ltd. (NasdaqGS:SSYS) for $1.3 billion.

Insider recently sold US$147k worth of stock

Consensus EPS estimates fall by 18%

Independent Director recently sold US$74k worth of stock

Consensus EPS estimates upgraded to US$0.57 loss

3D Systems Corporation Provides Earnings Guidance for the Year 2023

First quarter 2023 earnings released: US$0.23 loss per share (vs US$0.21 loss in 1Q 2022)

Price target increased by 8.8% to US$10.00

Full year 2022 earnings: EPS exceeds analyst expectations

Does 3D Systems (NYSE:DDD) Have A Healthy Balance Sheet?

3D Systems Introduces ProJet MJP 2500W Plus — New 3D Printing Solution for Jewelry Manufacturing Dramatically Improves Productivity

3D Systems Appoints Dr. Rebekah Gee as Member of Its Medical Advisory Board, Effective March 1, 2023

3D Systems Corporation to Report Q4, 2022 Results on Feb 28, 2023

3D Systems inks 3-year technical partnership with Stewart-Haas Racing

rms Company Scales Medical Device Production with Addition of 3D Systems’ DMP Flex 350 Dual

3D Systems Appoints Bert Bruce to its Medical Advisory Board

3D Systems: No Hurry - Still Not There Yet

Executive VP recently sold US$73k worth of stock